Neville Everett sold $175K of CI

Neville Everett (See Remarks) sold 617 shares of Cigna Group (CI) at $284.05 ($0.18M total) on 2026-09-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Neville Everett
Published Sep 8, 2026, 8:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 8:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CI
Neutral
high confidence
Mentioned
$CI
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CINeutralLow
01

Why it matters

The sale represents a modest reduction in insider stake and is unlikely to affect market perception.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

The sale was pre‑arranged under a 10b5‑1 plan, reducing the likelihood of it reflecting new information.

Relevance 3/10Novelty 4/10Timing: filing posted after market close on 2026-09-08

Background

Form 4 filings disclose insider transactions; investors monitor them for potential signals.

Company-level read

Ticker impact

$CINeutralHigh confidence
Context

Officer Neville Everett sold 617 Cigna shares for $175,258 at $284.05 each via a 10b5-1 plan, leaving 5,053 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale size is small relative to total holdings and market cap; insider sales of this magnitude rarely affect stock price.

Market effects

None; Cigna operates in health insurance with no sector-wide impact from this filing.

None; the transaction is company‑specific.

None; limited to Cigna shareholders.

Counterpoint

If the insider is reducing exposure, it could signal concerns about future performance.

Key entities

  • Cigna Group

    Health services and insurance provider (ticker CI).

  • Neville Everett

    Officer at Cigna Group who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UNHMed

UnitedHealth and other insurance stocks drag down the Dow after CMS proposes new anti-fraud rule

UnitedHealth (UNH), Humana (HUM), Cigna (CI), and CVS Health (CVS) stocks fell 8%, 8%, 2%, and 3% respectively, dragging down the Dow after CMS proposed a new anti-fraud rule. The rule, called CRUSH, aims to increase audits and recover improper payments, potentially saving $90B over 10 years. Oppenheimer analysts expect legal challenges and note savings may not be broad.

$UNHHighAI 8/10

Positive Medicaid signals, open enrollment trends: Recapping major payers' Q3 results

UnitedHealth Group reported Q3 profit of $4.1B (up from $2.3B YoY) and revenue of $112.7B. CVS Health earned $2.2B (up from a $4B loss YoY) on $108.4B revenue, announcing a split of its pharmacy business. Cigna and Elevance Health each posted $1.4B profit. Centene reduced losses to $71M (from $6.6B YoY) on $50.6B revenue. Humana saw $162M profit (down from $195M) on $41.15B revenue, with positive Medicare enrollment trends.